Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.93 USD | -3.20% | -12.08% | +59.11% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 277M |
---|---|---|---|---|---|
Net income 2024 * | -168M | Net income 2025 * | -193M | EV / Sales 2024 * | - |
Net cash position 2024 * | 208M | Net cash position 2025 * | 339M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.41
x | P/E ratio 2025 * |
-1.41
x | Employees | 80 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.79% |
Latest transcript on Ventyx Biosciences, Inc.
1 day | -3.20% | ||
1 week | -12.08% | ||
Current month | -28.55% | ||
1 month | -28.55% | ||
3 months | +92.65% | ||
6 months | -73.10% | ||
Current year | +59.11% |
Managers | Title | Age | Since |
---|---|---|---|
Raju Mohan
FOU | Founder | 68 | 18-10-31 |
Martin Auster
DFI | Director of Finance/CFO | 49 | 21-04-30 |
John Nuss
CTO | Chief Tech/Sci/R&D Officer | 65 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Somu Subramaniam
BRD | Director/Board Member | 69 | 18-10-31 |
Allison Hulme
BRD | Director/Board Member | 61 | 23-01-10 |
Sheila Gujrathi
CHM | Chairman | 53 | 21-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 2 M€ | -.--% | ||
0.09% | 0 M€ | 0.00% | - | |
0.05% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.93 | -3.20% | 529,730 |
24-04-25 | 4.06 | -4.25% | 586,706 |
24-04-24 | 4.24 | -2.53% | 596,383 |
24-04-23 | 4.35 | +1.16% | 445,605 |
24-04-22 | 4.3 | -3.80% | 1,100,280 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.11% | 277M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VTYX Stock